title: SPECT imaging of body dysmorphic disorder.
abstract: [99mTc]Hexamethylpropylene amine oxime (HMPAO) single photon emission computed tomography (SPECT) brain scans were undertaken in six subjects with body dysmorphic disorder (BDD). The scans showed a broad range of discrepant findings that do not immediately support a view of BDD as resting on either an obsessive-compulsive or affective disorder spectrum. Nevertheless, involvement of parietal regions is consistent with the characteristic altered body perception of BDD. These preliminary data highlight the need for further systematic functional imaging studies of this condition.
authors.affiliation: MRC Unit for Stress and Anxiety Disorders, University of Stellenbosch, P.O. Box 19063, Tygerberg, Cape Town, South Africa. pcarey@sun.ac.za
authors.forename: Paul
authors.initials: P
authors.lastname: Carey
authors.forename: Soraya
authors.initials: S
authors.lastname: Seedat
authors.forename: James
authors.initials: J
authors.lastname: Warwick
authors.forename: Ben
authors.initials: B
authors.lastname: van Heerden
authors.forename: Dan J
authors.initials: DJ
authors.lastname: Stein
mesh_terms: D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010091:Oximes / Q000378:metabolism; D013001:Somatoform Disorders / Q000000981:diagnostic imaging*; D019690:Technetium Tc 99m Exametazime / Q000378:metabolism; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*; D014057:Tomography, X-Ray Computed
chemical_list: D010091:Oximes; D019690:Technetium Tc 99m Exametazime